Electrical impedance myography as a biomarker for ALS

The Lancet Neurology

Volumn 8, Issue 3, 2009, Pages 226-

  Rutkove, Seward ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; ELECTRIC CURRENT; ELECTROMYOGRAPHY; HUMAN; IMPEDANCE; LETTER; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; ELECTRIC IMPEDANCE; ELECTROMYOGRAPHY; HUMANS;

EID: 60049086078     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70030-4     Document Type: Letter

References (5)

1. Turner M.R., Kiernan M.C., Leigh P.N., and Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8 (2009) 94-109
2. Rutkove S., Aaron R., and Shiffman C.A. Localized bioimpedance analysis in the evaluation of neuromuscular disease. Muscle Nerve 25 (2002) 390-397
3. Rutkove S.B., Zhang H., Schoenfeld D.A., et al. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin Neurophysiol 118 (2007) 2413-2418
4. Esper G.J., Shiffman C.A., Aaron R., Lee K.S., and Rutkove S.B. Assessing neuromuscular disease with multifrequency electrical impedance myography. Muscle Nerve 34 (2006) 595-602
5. Garmirian L.P., Chin A.B., and Rutkove S.B. Discriminating neurogenic from myopathic disease via measurement of muscle anisotropy. Muscle Nerve 39 (2009) 16-24